Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2020 Filed Jan 3, 2020 14:08 UTC |
FORLENZA VINCENT ADirector · Chairman, CEO and President
|
SaleCommon Stock | 33,365 | $271.28 | $9,051,257.20 |
DisclosureSEC source: 0001543407-20-000001 · edgar.xml · nonDerivative · entry 3 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,864 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $270.03 through $272.22. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on December 16, 2019. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 14:08 UTC |
FORLENZA VINCENT ADirector · Chairman, CEO and President
|
Disposition to issuerCommon Stock | 12,083 | $271.28 | $3,277,876.24 |
DisclosureSEC source: 0001543407-20-000001 · edgar.xml · nonDerivative · entry 2 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,229 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $270.03 through $272.22. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on December 16, 2019. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 14:08 UTC |
FORLENZA VINCENT ADirector · Chairman, CEO and President
|
Exercise / conversionCommon Stock | 45,448 | $72.12 | $3,277,709.76 |
DisclosureSEC source: 0001543407-20-000001 · edgar.xml · nonDerivative · entry 1 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:10 UTC |
Larson Betty DEVP HR & CHRO
|
Tax withholdingCommon Stock | 374 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000005 · edgar.xml · nonDerivative · entry 1 Larson Betty D · CIK 0001617903 · EVP HR & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,305 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:07 UTC |
Campion Simon DEVP and Segment President
|
Tax withholdingCommon Stock | 58 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000004 · edgar.xml · nonDerivative · entry 1 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,897 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:01 UTC |
Khichi Samrat S.EVP and General Counsel
|
Tax withholdingCommon Stock | 213 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000003 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,144 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 18:16 UTC |
RING TIMOTHY MDirector
|
Tax withholdingCommon Stock | 7,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000002 · edgar.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,278 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 20:34 UTC |
FORLENZA VINCENT ADirector · Chairman, CEO and President
|
GiftCommon Stock | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000077 · edgar.xml · nonDerivative · entry 1 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,864 Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:39 UTC |
Polen Thomas E JrExecutive Vice President
|
Exercise / conversionStock Appreciation Rights · Derivative | 10,000 | $0.00 Strike: $150.12 | $0.00 |
DisclosureSEC source: 0001543407-19-000075 · edgar.xml · derivative · entry 8 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Underlying: Common Stock · 10,000 shares Expires 2025-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2016. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:39 UTC |
Polen Thomas E JrExecutive Vice President
|
Exercise / conversionStock Appreciation Rights · Derivative | 3,907 | $0.00 Strike: $134.73 | $0.00 |
DisclosureSEC source: 0001543407-19-000075 · edgar.xml · derivative · entry 7 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,907 shares Expires 2024-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 25, 2015. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:39 UTC |
Polen Thomas E JrExecutive Vice President
|
SaleCommon Stock | 4,432 | $269.63 | $1,195,000.16 |
DisclosureSEC source: 0001543407-19-000075 · edgar.xml · nonDerivative · entry 6 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,117 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $269.16 through $269.98. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:39 UTC |
Polen Thomas E JrExecutive Vice President
|
Disposition to issuerCommon Stock | 5,568 | $269.63 | $1,501,299.84 |
DisclosureSEC source: 0001543407-19-000075 · edgar.xml · nonDerivative · entry 5 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,549 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $269.16 through $269.98. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:39 UTC |
Polen Thomas E JrExecutive Vice President
|
Exercise / conversionCommon Stock | 10,000 | $150.12 | $1,501,200.00 |
DisclosureSEC source: 0001543407-19-000075 · edgar.xml · nonDerivative · entry 4 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:39 UTC |
Polen Thomas E JrExecutive Vice President
|
SaleCommon Stock | 1,954 | $269.63 | $526,857.02 |
DisclosureSEC source: 0001543407-19-000075 · edgar.xml · nonDerivative · entry 3 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,117 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $269.16 through $269.98. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:39 UTC |
Polen Thomas E JrExecutive Vice President
|
Disposition to issuerCommon Stock | 1,953 | $269.63 | $526,587.39 |
DisclosureSEC source: 0001543407-19-000075 · edgar.xml · nonDerivative · entry 2 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,071 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $269.16 through $269.98. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:39 UTC |
Polen Thomas E JrExecutive Vice President
|
Exercise / conversionCommon Stock | 3,907 | $134.73 | $526,390.11 |
DisclosureSEC source: 0001543407-19-000075 · edgar.xml · nonDerivative · entry 1 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 14:45 UTC |
Mas Ribo AlbertoEVP and Pres, Life Sciences
|
Exercise / conversionStock Appreciation Rights · Derivative | 12,153 | $0.00 Strike: $134.73 | $0.00 |
DisclosureSEC source: 0001543407-19-000076 · edgar.xml · derivative · entry 6 Mas Ribo Alberto · CIK 0001686270 · EVP and Pres, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,153 shares Expires 2024-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 25, 2015. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 14:45 UTC |
Mas Ribo AlbertoEVP and Pres, Life Sciences
|
SaleCommon Stock | 11,860 | $269.51 | $3,196,388.60 |
DisclosureSEC source: 0001543407-19-000076 · edgar.xml · nonDerivative · entry 3 Mas Ribo Alberto · CIK 0001686270 · EVP and Pres, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,811 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $268.46 through $270.03. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Certain of the reported transactions were made pursuant to a 10b5-1 plan entered into on December 4, 2018. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 14:45 UTC |
Mas Ribo AlbertoEVP and Pres, Life Sciences
|
Disposition to issuerCommon Stock | 6,068 | $269.51 | $1,635,386.68 |
DisclosureSEC source: 0001543407-19-000076 · edgar.xml · nonDerivative · entry 2 Mas Ribo Alberto · CIK 0001686270 · EVP and Pres, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,671 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $268.46 through $270.03. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Certain of the reported transactions were made pursuant to a 10b5-1 plan entered into on December 4, 2018. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 14:45 UTC |
Mas Ribo AlbertoEVP and Pres, Life Sciences
|
Exercise / conversionCommon Stock | 12,153 | $134.73 | $1,637,373.69 |
DisclosureSEC source: 0001543407-19-000076 · edgar.xml · nonDerivative · entry 1 Mas Ribo Alberto · CIK 0001686270 · EVP and Pres, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $268.46 through $270.03. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Certain of the reported transactions were made pursuant to a 10b5-1 plan entered into on December 4, 2018. Read SEC document |
| December 14, 2019 Filed Dec 16, 2019 21:37 UTC |
Campion Simon DEVP and Segment President
|
Tax withholdingCommon Stock | 133 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000074 · edgar.xml · nonDerivative · entry 1 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,955 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 14:10 UTC |
Spoerel Thomas JVP Controller & Chief Acct Off
|
SaleCommon Stock | 506 | $267.95 | $135,582.70 |
DisclosureSEC source: 0001543407-19-000071 · edgar.xml · nonDerivative · entry 1 Spoerel Thomas J · CIK 0001790223 · VP Controller & Chief Acct Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,035 Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:15 UTC |
FORLENZA VINCENT ADirector · Chairman, CEO and President
|
Exercise / conversionStock Appreciation Rights · Derivative | 16,343 | $0.00 Strike: $76.64 | $0.00 |
DisclosureSEC source: 0001543407-19-000072 · edgar.xml · derivative · entry 6 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,343 shares Expires 2020-11-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 23, 2011. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:15 UTC |
FORLENZA VINCENT ADirector · Chairman, CEO and President
|
SaleCommon Stock | 11,626 | $265.57 | $3,087,516.82 |
DisclosureSEC source: 0001543407-19-000072 · edgar.xml · nonDerivative · entry 3 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,050 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $265.00 through $266.54. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on December 14, 2018. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:15 UTC |
FORLENZA VINCENT ADirector · Chairman, CEO and President
|
Disposition to issuerCommon Stock | 4,717 | $265.57 | $1,252,693.69 |
DisclosureSEC source: 0001543407-19-000072 · edgar.xml · nonDerivative · entry 2 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,676 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $265.00 through $266.54. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on December 14, 2018. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:15 UTC |
FORLENZA VINCENT ADirector · Chairman, CEO and President
|
Exercise / conversionCommon Stock | 16,343 | $76.64 | $1,252,527.52 |
DisclosureSEC source: 0001543407-19-000072 · edgar.xml · nonDerivative · entry 1 FORLENZA VINCENT A · CIK 0001221787 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:17 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
Exercise / conversionStock Appreciation Rights · Derivative | 4,236 | $0.00 Strike: $242.10 | $0.00 |
DisclosureSEC source: 0001543407-19-000073 · edgar.xml · derivative · entry 4 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,710 Underlying: Common Stock · 4,236 shares Expires 2028-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2019. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:17 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
SaleCommon Stock | 339 | $263.23 | $89,234.97 |
DisclosureSEC source: 0001543407-19-000073 · edgar.xml · nonDerivative · entry 3 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,310 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $263.19 through $263.24. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:17 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
Disposition to issuerCommon Stock | 3,897 | $263.23 | $1,025,807.31 |
DisclosureSEC source: 0001543407-19-000073 · edgar.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,649 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $263.19 through $263.24. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:17 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
Exercise / conversionCommon Stock | 4,236 | $242.10 | $1,025,535.60 |
DisclosureSEC source: 0001543407-19-000073 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 18:17 UTC |
Campion Simon DEVP and Segment President
|
Tax withholdingCommon Stock | 147 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000069 · edgar.xml · nonDerivative · entry 1 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,088 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| December 06, 2019 Filed Dec 6, 2019 21:11 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
SaleCommon Stock | 312 | $261.51 | $81,591.12 |
DisclosureSEC source: 0001543407-19-000068 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,310 Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 18:59 UTC |
Campion Simon DEVP and Segment President
|
GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000067 · edgar.xml · nonDerivative · entry 1 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,235 Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 18:24 UTC |
Spoerel Thomas JVP Controller & Chief Acct Off
|
GrantStock Appreciation Rights · Derivative | 1,894 | $0.00 Strike: $255.22 | $0.00 |
DisclosureSEC source: 0001543407-19-000056 · edgar.xml · derivative · entry 5 Spoerel Thomas J · CIK 0001790223 · VP Controller & Chief Acct Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,894 Underlying: Common Stock · 1,894 shares Expires 2029-11-26 F5 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2020. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 18:24 UTC |
Spoerel Thomas JVP Controller & Chief Acct Off
|
GrantCommon Stock | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000056 · edgar.xml · nonDerivative · entry 3 Spoerel Thomas J · CIK 0001790223 · VP Controller & Chief Acct Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,130 F3 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 18:24 UTC |
Spoerel Thomas JVP Controller & Chief Acct Off
|
Tax withholdingCommon Stock | 248 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000056 · edgar.xml · nonDerivative · entry 2 Spoerel Thomas J · CIK 0001790223 · VP Controller & Chief Acct Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 945 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 18:24 UTC |
Spoerel Thomas JVP Controller & Chief Acct Off
|
GrantCommon Stock | 435 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000056 · edgar.xml · nonDerivative · entry 1 Spoerel Thomas J · CIK 0001790223 · VP Controller & Chief Acct Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,193 F1 · shares: Represents shares vesting under performance units granted on November 26, 2016. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:39 UTC |
Larson Betty DEVP HR & CHRO
|
GrantStock Appreciation Rights · Derivative | 9,260 | $0.00 Strike: $255.22 | $0.00 |
DisclosureSEC source: 0001543407-19-000066 · edgar.xml · derivative · entry 2 Larson Betty D · CIK 0001617903 · EVP HR & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,260 Underlying: Common Stock · 9,260 shares Expires 2029-11-26 F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2020. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:39 UTC |
Larson Betty DEVP HR & CHRO
|
Tax withholdingCommon Stock | 164 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000066 · edgar.xml · nonDerivative · entry 1 Larson Betty D · CIK 0001617903 · EVP HR & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,679 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:27 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
GrantStock Appreciation Rights · Derivative | 18,119 | $0.00 Strike: $255.22 | $0.00 |
DisclosureSEC source: 0001543407-19-000064 · edgar.xml · derivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,119 Underlying: Common Stock · 18,119 shares Expires 2029-11-26 F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2020. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:27 UTC |
Kaltenbach PatrickEVP & Pres Life Sciences
|
Tax withholdingCommon Stock | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000064 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,622 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:33 UTC |
Khichi Samrat S.EVP and General Counsel
|
GrantStock Appreciation Rights · Derivative | 12,627 | $0.00 Strike: $255.22 | $0.00 |
DisclosureSEC source: 0001543407-19-000065 · edgar.xml · derivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,627 Underlying: Common Stock · 12,627 shares Expires 2029-11-26 F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2020. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:33 UTC |
Khichi Samrat S.EVP and General Counsel
|
Tax withholdingCommon Stock | 192 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000065 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,357 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:15 UTC |
Conroy AlexandreEVP of Integrated Supply Chain
|
GrantStock Appreciation Rights · Derivative | 12,627 | $0.00 Strike: $255.22 | $0.00 |
DisclosureSEC source: 0001543407-19-000062 · edgar.xml · derivative · entry 4 Conroy Alexandre · CIK 0001551713 · EVP of Integrated Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,627 Underlying: Common Stock · 12,627 shares Expires 2029-11-26 F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2020. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:15 UTC |
Conroy AlexandreEVP of Integrated Supply Chain
|
Tax withholdingCommon Stock | 2,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000062 · edgar.xml · nonDerivative · entry 2 Conroy Alexandre · CIK 0001551713 · EVP of Integrated Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,115 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:15 UTC |
Conroy AlexandreEVP of Integrated Supply Chain
|
GrantCommon Stock | 2,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000062 · edgar.xml · nonDerivative · entry 1 Conroy Alexandre · CIK 0001551713 · EVP of Integrated Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,280 F1 · shares: Represents shares vesting under performance units granted on November 26, 2016. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:21 UTC |
Campion Simon DEVP and Segment President
|
GrantStock Appreciation Rights · Derivative | 12,963 | $0.00 Strike: $255.22 | $0.00 |
DisclosureSEC source: 0001543407-19-000063 · edgar.xml · derivative · entry 2 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,963 Underlying: Common Stock · 12,963 shares Expires 2029-11-26 F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2020. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:21 UTC |
Campion Simon DEVP and Segment President
|
Tax withholdingCommon Stock | 123 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000063 · edgar.xml · nonDerivative · entry 1 Campion Simon D · CIK 0001751919 · EVP and Segment President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,285 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 18:59 UTC |
Polen Thomas E JrExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 76,810 | $0.00 Strike: $255.22 | $0.00 |
DisclosureSEC source: 0001543407-19-000060 · edgar.xml · derivative · entry 3 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,810 Underlying: Common Stock · 76,810 shares Expires 2029-11-26 F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2020. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 18:59 UTC |
Polen Thomas E JrExecutive Vice President
|
Tax withholdingCommon Stock | 3,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000060 · edgar.xml · nonDerivative · entry 2 Polen Thomas E Jr · CIK 0001621793 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,117 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.